welbournes

The Department of Health and Social Care (DHSC) has today (29/01/2026) confirmed the following list of price concessions for January 2026: Drug Pack size Price concession Aspirin 75mg tablets 28 £2.95 Chloramphenicol 0.5% eye drops 10 £2.75 Cimetidine 400mg tablets 60 £5.58 Co-codamol 30mg/500mg capsules 100 £5.68 Diclofenac sodium 50mg gastro-resistant tablets 28 £6.86 Glycerol [...]

The post January 2026 Price Concessions 3rd Update appeared first on Community Pharmacy England.

Community Pharmacy England has seen a large number of products with increases to their list prices on 1 January 2026. Following the price change mechanism rules, price changes for generic products up to and including the 8th of the month take effect for prescriptions dispensed in that same month. Any price changes after the 8th [...]

The post January 2026 reimbursement prices for Omeprazole Rosemont Pharmaceutical Ltd products appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches. MSN/2026/004 Tier 2 – Medium impact Date of issue: 28 January 2026 Oxybutynin (Kentera®) 3.9mg/24hours transdermal patches are out of stock until late-February 2026. Oxybutynin 5mg and 10mg modified-release tablets remain available and can support increased [...]

The post Medicine Supply Notification: Oxybutynin (Kentera® ) 3.9mg/24hours transdermal patches appeared first on Community Pharmacy England.

Update 06/02/2026: Updated to include additional products/batches: Product Batch code Expiry Aptamil First Infant Formula (800 g) All dates from 9 July 2026 to 4 December 2026 All dates from 9 July 2026 to 4 December 2026 Aptamil First Infant Formula (700 g) All dates from 22 August 2026 to 26 November 2026 All dates from 22 [...]

The post FSA recall: Aptamil First Infant Formula (Nutricia Ltd) – Updated appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited Drug alert number: EL(26)A/03 Date issued: 27 January 2026 Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille [...]

The post MHRA Class 4 Medicines Defect Notification: Ocumont Eye Ointment 1% w/w Blumont Pharma Limited appeared first on Community Pharmacy England.